Qiyou Ding

750 total citations · 1 hit paper
17 papers, 483 citations indexed

About

Qiyou Ding is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Qiyou Ding has authored 17 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Pharmacology. Recurrent topics in Qiyou Ding's work include Gut microbiota and health (9 papers), Ginseng Biological Effects and Applications (6 papers) and Traditional Chinese Medicine Studies (4 papers). Qiyou Ding is often cited by papers focused on Gut microbiota and health (9 papers), Ginseng Biological Effects and Applications (6 papers) and Traditional Chinese Medicine Studies (4 papers). Qiyou Ding collaborates with scholars based in China. Qiyou Ding's co-authors include Linhua Zhao, Xiaolin Tong, Jiaxing Tian, Zezheng Gao, Wei Zhang, Jing Ma, Yujiao Zheng, Fengmei Lian, Haiyu Zhang and De Jin and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and Journal of Ethnopharmacology.

In The Last Decade

Qiyou Ding

17 papers receiving 475 citations

Hit Papers

Gut microbial beta-glucuronidase: a vital regulator in fe... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiyou Ding China 11 258 85 82 70 69 17 483
Yujiao Zheng China 13 242 0.9× 128 1.5× 103 1.3× 85 1.2× 104 1.5× 37 558
Jiabao Liao China 11 232 0.9× 62 0.7× 84 1.0× 48 0.7× 64 0.9× 32 418
Guangyao Zhou China 15 251 1.0× 61 0.7× 97 1.2× 39 0.6× 90 1.3× 38 730
Zezheng Gao China 15 392 1.5× 97 1.1× 120 1.5× 114 1.6× 101 1.5× 30 694
Rensong Yue China 13 165 0.6× 41 0.5× 68 0.8× 49 0.7× 71 1.0× 52 452
Davood Soleimani Iran 16 117 0.5× 79 0.9× 95 1.2× 83 1.2× 88 1.3× 48 690
Keihan Ghatreh Samani Iran 15 181 0.7× 70 0.8× 36 0.4× 68 1.0× 63 0.9× 58 545
Raluca Anca Corb Aron Romania 7 172 0.7× 44 0.5× 76 0.9× 75 1.1× 41 0.6× 16 474
Weibo Wen China 11 189 0.7× 54 0.6× 62 0.8× 46 0.7× 58 0.8× 38 397

Countries citing papers authored by Qiyou Ding

Since Specialization
Citations

This map shows the geographic impact of Qiyou Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiyou Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiyou Ding more than expected).

Fields of papers citing papers by Qiyou Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiyou Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiyou Ding. The network helps show where Qiyou Ding may publish in the future.

Co-authorship network of co-authors of Qiyou Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qiyou Ding. A scholar is included among the top collaborators of Qiyou Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiyou Ding. Qiyou Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Boxun, Zhen Luo, Xiaotong Yu, et al.. (2023). Microbiome and metabolome dysbiosis analysis in impaired glucose tolerance for the prediction of progression to diabetes mellitus. Journal of genetics and genomics. 51(1). 75–86. 7 indexed citations
2.
Ding, Qiyou, et al.. (2023). Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes. 15(1). 2236749–2236749. 108 indexed citations breakdown →
4.
Ding, Qiyou, et al.. (2022). Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. Frontiers in Immunology. 13. 883410–883410. 27 indexed citations
5.
Chen, Keyu, Zezheng Gao, Qiyou Ding, et al.. (2022). Effect of natural polyphenols in Chinese herbal medicine on obesity and diabetes: Interactions among gut microbiota, metabolism, and immunity. Frontiers in Nutrition. 9. 962720–962720. 11 indexed citations
6.
Zhang, Boxun, et al.. (2022). Global research trends on the links between the gut microbiota and diabetes between 2001 and 2021: A bibliometrics and visualized study. Frontiers in Microbiology. 13. 1011050–1011050. 9 indexed citations
7.
Zhang, Boxun, et al.. (2022). Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Frontiers in Cellular and Infection Microbiology. 12. 855075–855075. 33 indexed citations
8.
Sha, Di, Han Lin, Xuedong An, et al.. (2021). In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications. Journal of Ethnopharmacology. 276. 114180–114180. 37 indexed citations
9.
10.
Zheng, Yujiao, et al.. (2020). The effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes. Medicine. 99(38). e22233–e22233. 4 indexed citations
11.
Zheng, Yujiao, Qiyou Ding, Yu Wei, et al.. (2020). Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis. Phytomedicine. 88. 153455–153455. 51 indexed citations
12.
Li, Qingwei, Han Wang, Xiuyang Li, et al.. (2020). The role played by traditional Chinese medicine in preventing and treating COVID-19 in China. Frontiers of Medicine. 14(5). 681–688. 54 indexed citations
13.
Han, Lin, Linhua Zhao, Mingliang Zhang, et al.. (2020). A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses. Frontiers in Microbiology. 11. 173–173. 14 indexed citations
14.
Ding, Qiyou, Jiaxing Tian, Min Li, et al.. (2020). Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Frontiers in Cellular and Infection Microbiology. 10. 530160–530160. 19 indexed citations
15.
Ding, Qiyou, et al.. (2020). Clinical application and dosage of prepared rehmannia root. 36(2). 228–230. 1 indexed citations
16.
Jin, De, Jiaxing Tian, Qi Bao, et al.. (2019). Does Adjuvant Treatment with Chinese Herbal Medicine to Antidiabetic Agents Have Additional Benefits in Patients with Type 2 Diabetes? A System Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 13 indexed citations
17.
Tian, Jiaxing, De Jin, Qi Bao, et al.. (2019). Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 21(8). 1801–1816. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026